Ken Griffin acquired 21.4 Thousand AgeX Therapeutics shares worth $238 Thousand. That's 0.00% of their equity portfolio (3979th largest holding). The first AgeX Therapeutics trade was made in Q1 2020. Since then Ken Griffin bought shares five more times and sold shares on seven occasions. The stake costed the investor $11.2 Thousand, netting the investor a gain of 2022% so far.